Funding search · EIN 366975534 · Dallas, TX

Dr Ralph & Marian Falk Medical Research Tr

Search the web for this foundation ↗Full IRS filings ↗

$32.5M
in grants paid
141
grants
38
recipients
2021–2024
filing years

Recent grants

The 100 largest recent grants from this foundation’s filings, newest year first.

  • $355,809

    Case Western Reserve University · Cleveland, OH · 2024

    Immunotherapy for b cell

  • $348,252

    Yale University - School of Medicine · New Haven, CT · 2024

    Making cancer cells look

  • $340,879

    Indiana University · Bloomington, IN · 2024

    Pim2 modulator-multiple

  • $334,583

    Medical College of Wisconsin · Milwaukee, WI · 2024

    Pain therapy - sensory

  • $333,333

    Thomas Jefferson University · Philadelphia, PA · 2024

    Protacs for targeting brca

  • $331,873

    Cleveland Clinic Foundation · Cleveland, OH · 2024

    Development of new drug for

  • $330,487

    Board Regents of University of Wisconsin · Milwaukee, WI · 2024

    Improve diagnosis of breast

  • $315,981

    Medical College of Wisconsin · Milwaukee, WI · 2024

    New drugs to treat

  • $308,897

    Universityof Minnesota · Minneapolis, MN · 2024

    T3 therapy - heart failure

  • $284,681

    University of Minnesota · Minneapolis, MN · 2024

    Optimized mechanism based

  • $268,735

    University of Chicago · Chicago, IL · 2024

    Metastic lung cancer phase

  • $257,044

    Purdue University · West Lafayette, IN · 2024

    Advancing micro rnas as

  • $210,398

    Northwestern University · Evanston, IL · 2024

    Therapy for chronic kidney

  • $208,319

    University of Iowa · Iowa City, IA · 2024

    Vascular health targeting

  • $203,837

    University of Minnesota · Minneapolis, MN · 2024

    Systemic bacteremia - host

  • $186,955

    Cleveland Clinic Foundation · Cleveland, OH · 2024

    Treatment of complex

  • $178,604

    Ohio State University · Columbus, OH · 2024

    Melanoma onset & recurrence

  • $176,327

    University of Minnesota · Minneapolis, MN · 2024

    Develop il-15 - malaria

  • $175,864

    Shirley Ryan Ability Lab · Chicago, IL · 2024

    Restore diaphragm - nerve

  • $175,575

    Mayo Clinic · Rochester, MN · 2024

    Cd-19 targeted car-msc19 in

  • $175,000

    University of Cincinnati · Cleveland, OH · 2024

    Develop improved method of

  • $175,000

    Washington University · St Louis, MO · 2024

    Stem cell derived islets

  • $175,000

    Brown University of Providence · Providence, RI · 2024

    Repurposing clopidogrel to

  • $175,000

    Loyola University of Chicago · Chicago, IL · 2024

    Inhibitors for triple

  • $175,000

    Case Western Reserve University · Cleveland, OH · 2024

    Pharma strategy to treat

  • $175,000

    Michigan State University · East Lansing, MI · 2024

    Develop new odc inhibitors

  • $175,000

    Regents of University of Michigan · Ann Arbor, MI · 2024

    Neuro-cardiac mechanisms of

  • $175,000

    Regents of University of Michigan · Ann Arbor, MI · 2024

    Antibody cns delivery and

  • $173,839

    University of Minnesota · Minneapolis, MN · 2024

    Sound waves assessment via

  • $173,769

    Children'S Hospital Medical Center · Cincinnati, OH · 2024

    Autoimmune arthritis

  • $173,717

    Washington University · St Louis, MO · 2024

    Vagus nerve stimulation -

  • $173,096

    Brown University of Providence · Providence, RI · 2024

    Gene therapy for

  • $169,910

    Indiana University · Bloomington, IN · 2024

    Traumatic brain injury

  • $168,188

    Northwestern University · Evanston, IL · 2024

    Antibodies treatment of

  • $161,487

    Yale University - School of Medicine · New Haven, CT · 2024

    Anti vb2 antibody drug for

  • $151,908

    Ohio State University · Columbus, OH · 2024

    Develop new therapy for

  • $150,426

    University of Minnesota · Minneapolis, MN · 2024

    Severity measure- adductor

  • $57,018

    Indiana University · Bloomington, IN · 2024

    Inhibitors-peanut specific

  • $497,018

    University of Cincinnati · Cleveland, OH · 2023

    Inhibitors targeting peanut

  • $495,146

    Brown University of Providence · Providence, RI · 2023

    Anti-malaria drugs targetng

  • $377,004

    Medical College of Wisconsin · Milwaukee, WI · 2023

    New drugs to treat

  • $343,159

    Case Western Reserve University · Cleveland, OH · 2023

    B cell cancer therapy using

  • $336,255

    Cleveland Clinic Foundation · Cleveland, OH · 2023

    Development of new drug for

  • $333,333

    Thomas Jefferson University · Philadelphia, PA · 2023

    Protacs for targeting brca

  • $318,948

    Medical College of Wisconsin · Milwaukee, WI · 2023

    Development of sensory

  • $235,086

    Universityof Minnesota · Minneapolis, MN · 2023

    Thyroid hormone

  • $200,685

    University of Chicago · Chicago, IL · 2023

    Tumor anueploidy -

  • $197,879

    Ohio State University · Columbus, OH · 2023

    Develop new therapy for

  • $190,000

    Yale University School of Medicine · New Haven, CT · 2023

    Targeted degredation of

  • $190,000

    Regents of University of Michigan · Ann Arbor, MI · 2023

    Device to predict

  • $190,000

    Childrens Hospital Medical Center · Cincinnati, OH · 2023

    Lupus nephritis biomarkers

  • $190,000

    Cleveland Clinic Foundation · Cleveland, OH · 2023

    New weapons to fight

  • $187,210

    State University of Iowa · Iowa City, IA · 2023

    Improve hypoxic tumor mgmt

  • $181,905

    Mayo Clinic · Rochester, MN · 2023

    In vivo generation of car t

  • $179,775

    Indiana University · Bloomington, IN · 2023

    Traumatic brain injury

  • $177,796

    Rehabilitation Institute of Chicago · Chicago, IL · 2023

    Repurpose 5-azacytidine -

  • $177,271

    Indiana University · Bloomington, IN · 2023

    Novel minimally invasive

  • $176,215

    Stanford University · Stanford, CA · 2023

    Metabolic pausing - organ

  • $175,216

    Washington University · St Louis, MO · 2023

    Zika virus genetic arming-

  • $175,000

    Board Regents of University of Wisconsin · Milwaukee, WI · 2023

    Diabetes stem cell cure -

  • $175,000

    University of Cincinnati · Cleveland, OH · 2023

    Develop improved method of

  • $175,000

    University of Chicago · Chicago, IL · 2023

    Development of syngap1

  • $175,000

    Michigan State University · East Lansing, MI · 2023

    Develop new odc inhibitors

  • $175,000

    Brown University of Providence · Providence, RI · 2023

    Repurposing clopidogrel to

  • $175,000

    Case Western Reserve University · Cleveland, OH · 2023

    Blocking peptide treatment

  • $174,425

    Mayo Clinic · Rochester, MN · 2023

    Cd-19 targeted car-msc19 in

  • $173,673

    University of Minnesota · Minneapolis, MN · 2023

    Develop il-15 - malaria

  • $173,017

    Yale University School of Medicine · New Haven, CT · 2023

    Develop phage therapy to

  • $168,835

    University of Minnesota · Minneapolis, MN · 2023

    Severity measure- adductor

  • $163,974

    Stanford University · Stanford, CA · 2023

    Novel dna-guided argonaute

  • $150,887

    Thomas Jefferson University · Philadelphia, PA · 2023

    Chemokine antagonist for

  • $145,339

    University of Cincinnati · Cleveland, OH · 2023

    Targeting sexual cycle of

  • $136,995

    University of Cincinnati · Cleveland, OH · 2023

    Letrozole- novel

  • $100,000

    Indiana University · Bloomington, IN · 2023

    Novel rxr agonist for

  • $18,026

    Northwestern University · Evanston, IL · 2023

    T cell therapy for

  • $504,854

    Brown University of Providence · Providence, RI · 2022

    Anti-malaria drugs targetng

  • $445,923

    Indiana University · Bloomington, IN · 2022

    Targeting peanut-specific

  • $346,469

    Medical College of Wisconsin Sen Neuron · Milwaukee, WI · 2022

    Development of sensory

  • $333,333

    Thomas Jefferson University · Philadelphia, PA · 2022

    Protacs for targeting brca

  • $331,974

    Northwestern University · Evanstone, IL · 2022

    T cell thearpy for

  • $301,032

    Case Western Reserve University · Cleveland, OH · 2022

    B cell cancer therapy using

  • $211,322

    University of Cincinnati · Cleveland, OH · 2022

    Studies for repurposing

  • $204,619

    University of Cincinnati · Cleveland, OH · 2022

    Targeting sexual cycle of

  • $200,000

    Cleveland Clinic Foundation · Cleveland, OH · 2022

    New weapons to fight

  • $200,000

    Regents of University of Michigan · Ann Arbor, MI · 2022

    Device to predict

  • $200,000

    Childrens Hospital Medical Center · Cincinnati, OH · 2022

    Lupus nephritis biomarkers

  • $200,000

    Yale University School of Medicine · New Haven, CT · 2022

    Targeted degredation of

  • $196,613

    Thomas Jefferson University · Philadelphia, PA · 2022

    Chemokine antagonist for

  • $190,000

    Childrens Hospital Medical Center · Cincinnati, OH · 2022

    Develop human liver

  • $190,000

    Stanford University - Development Services · Redwood City, CA · 2022

    Novel therapies - major

  • $190,000

    Board Regents of University of Wisconsin · Milwaukee, WI · 2022

    Nanoparticles target

  • $175,188

    Yale University School of Medicine · New Haven, CT · 2022

    Develop phage therapy to

  • $175,000

    Case Western Reserve University · Cleveland, OH · 2022

    Blocking peptide treatment

  • $175,000

    University of Chicago · Chicago, IL · 2022

    Development of syngap1

  • $175,000

    Board Regents of University of Wisconsin · Milwaukee, WI · 2022

    Diabetes stem cell cure -

  • $174,784

    Washington University · St Louis, MO · 2022

    Zika virus genetic arming-

  • $173,785

    Stanford University - Development Services · Redwood City, CA · 2022

    Metabolic pausing - organ

  • $172,729

    Indiana University · Bloomington, IN · 2022

    Novel minimally invasive

  • $171,431

    Rehabilitation Institute of Chicago · Chicago, IL · 2022

    Repurpose 5-azacytidine -

  • $168,095

    Mayo Clinic · Minneapolis, MN · 2022

    In vivo generation - car t

Grants already paid are the record; PaperOrbit reads your paper and finds the foundations whose record matches it — then explains why.

Start with one paper

Source: IRS Form 990-PF, Part XV, as filed by the foundation. These are grants already paid — a record of what this funder backs, not an open call. Most private foundations do not accept unsolicited applications; the route in is usually a program officer.